8-K: Supernus Pharmaceuticals to Announce Third Quarter 2024 Results on November 4th

Supernus Pharmaceuticals will release its third quarter 2024 financial results after market close on November 4, 2024, followed by a conference call and webcast.

Summary

• Supernus Pharmaceuticals, a biopharmaceutical company focused on central nervous system (CNS) treatments, will announce its third quarter 2024 financial and business results on November 4, 2024.
• The company will host a conference call and webcast at 4:30 p.m. ET on November 4, 2024, to discuss the results.
• The call will include prepared remarks from management, a discussion of business results, and a question-and-answer session.
• A live webcast will be available on the company's Investor Relations website, and a replay will be available for 60 days after the call.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it is a routine announcement of an upcoming earnings release and conference call. There is no indication of any negative news.

Positives

• The company is providing a clear date and time for the release of its third quarter 2024 results.
• Supernus is offering multiple ways for investors to access the information, including a live webcast and a replay.
• Management will be available to answer questions during the conference call.

Risks

• There are no specific risks mentioned in this announcement, but the market's reaction to the financial results could impact the company's stock price.

Future Outlook

The company will be discussing its third quarter 2024 results and business performance on the conference call, which may provide insights into future performance.

Management Comments

• Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host the conference call.

Industry Context

This announcement is typical for publicly traded biopharmaceutical companies, which regularly report quarterly financial results and hold conference calls to discuss their performance with investors.

Comparison to Industry Standards

• The timing of the earnings release and conference call is consistent with industry practices for publicly traded companies.
• Many biopharmaceutical companies, such as Biogen, Amgen, and Gilead Sciences, follow a similar pattern of releasing quarterly results and hosting investor calls.

Stakeholder Impact

• Shareholders will receive information about the company's financial performance for the third quarter of 2024.
• Investors will have the opportunity to ask questions during the conference call.
• The company's performance may impact the stock price.

Next Steps

• Supernus Pharmaceuticals will release its third quarter 2024 financial results on November 4, 2024.
• The company will host a conference call and webcast on November 4, 2024, at 4:30 p.m. ET.

Key Dates

Keywords

Supernus Pharmaceuticals, Financial Results, Third Quarter, Conference Call, Webcast, CNS, Biopharmaceutical, Investor Relations